Ritonavir Completed Phase 4 Trials for Hepatitis C Viral Infection Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02734173Pilot HCV Direct Acting Antiviral Therapy and Metabolism